Anjana Ranganathan

984 citations
11 papers · 783 indexed · 1 hit paper · h-index 6
Topics
Palliative Care and End-of-Life Issues (4 papers)Childhood Cancer Survivors' Quality of Life (2 papers)CAR-T cell therapy research (2 papers)
Partner nations
United StatesFrance

In The Last Decade

Anjana Ranganathan

11 papers receiving 768 citations

Hit Papers

Tumor-associated neutrophils stimulate T cell responses i...20142026201820222014100200300400

Peers

Anjana Ranganathan
Comparison fields: 5 of 64
  • Immunology 487
  • Oncology 402
  • Molecular Biology 152
  • Pulmonary and Respiratory Medicine 94
  • Biomedical Engineering 67
Replace Hendrik W. van Deventer with:
Hendrik W. van Deventer United States
Jesse T. Davidson United States
Karen O. Dixon United States
Matthew J. Reilley United States
Diana P. English United States
Abigail L. Sedlacek United States
Qianshan Tao China
Hyungjun Jeon United States
Pierre Teira Canada
Toni Valković Croatia
Anjana Ranganathan relative to Hendrik W. van Deventer United States Hendrik W. van Deventer's profile →
Citations per field
00.5×3.9×
Hendrik W. van Deventer · 1×
Citations per year

Countries citing papers authored by Anjana Ranganathan

Since Specialization
Citations

This map shows the geographic impact of Anjana Ranganathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjana Ranganathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjana Ranganathan more than expected).

Fields of papers citing papers by Anjana Ranganathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjana Ranganathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjana Ranganathan. The network helps show where Anjana Ranganathan may publish in the future.

Co-authorship network of co-authors of Anjana Ranganathan

This figure shows the co-authorship network connecting the top 25 collaborators of Anjana Ranganathan. A scholar is included among the top collaborators of Anjana Ranganathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjana Ranganathan. Anjana Ranganathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 5
2 44
3
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancerbreakdown →
495
4 21
5 106
6 65
7 40
8 1
9 1
10 4
11 1

About Anjana Ranganathan

Anjana Ranganathan is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 11 papers that have together received 783 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (4 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (487 citations), Oncology (402 citations) and Cancer Research (58 citations). Anjana Ranganathan has collaborated with scholars based in United States and France. Frequent co-authors include Steven Μ. Albelda, Anil Vachani, Jon G. Quatromoni, Pratik Bhojnagarwala, Leslie A. Litzky, José R. Conejo-García, Evgeniy Eruslanov, Sunil Singhal, Wayne W. Hancock and Charuhas Deshpande. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026